Who’s at Risk for Contracting C-Difficile?

Jul 23, 2015Clinical Trial

Clostridium Difficile, or C-Diff for short, doesn’t play favorites when it comes to making you sick. This bacterium can affect people with no risk factors just as easily as those with weakened immune systems. Although it doesn’t generally affect people with a healthy gut, C-Diff is easier to contract for certain audiences and in specific circumstances.

C-Diff spores can live on hard surfaces for a long time, so it’s easy for a person to transfer it from an infected surface to his or her mouth by hand. And if the person who comes in contact with C-Diff doesn’t have thriving “good” bacteria in his or her stomach and intestinal tract to fight it off, C-Diff can quickly take root and grow out of control.

Every day, this good bacteria “fights the good fight” for us by keeping bad bacteria at bay. However, when we ingest antibiotics, they destroy both the bad and the good bacteria that protect us from infection. So, your chances of contracting C-Diff when on a course of antibiotics (or on multiple antibiotics) increases 7- to 10-fold.

Other risk factors include:

Age (of the 350,000 Americans who are hospitalized for C-Diff annually, 77% of those cases are people over the age of 50.)
Staying in medical care facilities
Having a medical procedure
Experiencing diarrhea after being hospitalized

Symptoms to be aware of include:

Fever
Nausea
Watery diarrhea
Abdominal pain
Loss of appetite
Not passing stool
Inflammation of the colon (colitis or IBS)

C-Diff Vaccine Clinical Trial Utah

If you or someone you love is entering a long-term care facility or has an upcoming hospitalization, he or she may qualify for a clinical research study in Salt Lake City, Utah, by JBR Clinical Research.

Participants that are selected for the study will receive a no-charge vaccination, study-related procedures and compensation for time and travel.

Basic qualifications are:

40-75 years of age

If you qualify, you may receive:

Study-related exam
No-charge investigational C-Diff vaccination
Compensation for time and travel related to the study

To learn more or to see if you qualify, contact JBR Clinical Research online today.

Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

At CenExel Clinical Research, our top priorities are the safety and health of our patients and employees. For our Centers of Excellence to provide the highest quality of clinical research, we established and maintain a COVID-19 Task Force with representatives from every Center. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication.

Our clinical operations continue, and we have implemented the following additional safety measures:

Enhanced screening of everyone entering any of our facilities before they are admitted into our offices or clinical areas
Reinforced internal communication regarding the COVID-19 situation, CDC and SHRM recommendations, digital team meetings, and the importance of using sick leave for anyone who has signs, symptoms, or recent exposure to someone with suspected or diagnosed COVID-19
Additional cleaning and disinfecting materials provided through our clinic and office areas
Cross-training and preparations for contingency plans if key staff need to stay home

We will continue to monitor the current situation, coordinate with the proper authorities, and update our policies and procedures as needed to ensure the safety of our patients and employees.

Who’s at Risk for Contracting C-Difficile?

Share This Resource

​Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

Update on COVID-19